Analyze Diet

Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma.

Abstract: A 2-year field study was performed to determine the capability of increasing Rhodococcus equi specific antibody in foals via plasma transfusion or mare vaccination, to determine the kinetics of R. equi (ELISA) antibody decay and to assess the protective effects of these procedures in foals on a farm endemic for R. equi. Plasma donors were vaccinated with a killed R. equi bacterin and produced high levels of anti-R. equi antibodies, which were harvested by plasmapheresis. In Experiment 1, 68 foals were given 1 litre of hyperimmune plasma intravenously (i.v.) between 1-60 days of age. Foal plasma R. equi antibody was significantly increased and high levels of R. equi antibody (ELISA) were maintained for 60 days. No R. equi pneumonia developed in any foals receiving plasma. In Experiment 2, 99 pregnant mares were vaccinated with R. equi bacterin at 30, 60 and 90 days before foaling. Group 1 foals (101:85 from R. equi immunized mares) also received plasma transfusions and Group 2 foals (14), from R. equi immunized mares, did not receive plasma transfusions. Pregnant mare immunization increased colostrum R. equi antibody significantly. Eight foals showed failure of transfer of specific R. equi antibody. The incidence of R. equi pneumonia was 2.9% in Group 1 foals and 43% in Group 2 foals. Vaccination of pregnant mares did not provide protection against R. equi pneumonia; however, plasma transfusion with hyperimmune plasma administered prior to R. equi exposure was significantly protective in foals.
Publication Date: 1991-01-01 PubMed ID: 1795301
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study assesses the protection offered against Rhodococcus equi bacterium in foals through plasma transfusion or mare vaccination. The results indicate that plasma transfusions were significantly effective in protecting foals against R. equi pneumonia, while mare vaccination was not.

Study Design and Methods

  • The researchers conducted a study over two years to understand the ability to elevate foals’ R. equi specific antibody through plasma transfusion or mare vaccination on a farm where R. equi was endemic.
  • The researchers treated plasma donors with a killed R. equi bacterin, which generated high levels of anti-R. equi antibodies. They then harvested these antibodies through a process called plasmapheresis.

Experiment 1: Plasma Transfusion in Foals

  • In the first experiment, the researchers administered 1 litre of hyperimmune plasma to each of the 68 foals aged between 1 to 60 days.
  • The foals experienced a significant increase in their R. equi antibody levels, which remained high for 60 days.
  • None of the foals that received plasma developed R. equi pneumonia. This suggested that the transfusion of hyperimmune plasma effectively protected the foals against the pneumonia caused by R. equi.

Experiment 2: Pregnant Mare Vaccination

  • In the second experiment, the researchers vaccinated 99 pregnant mares with R. equi bacterin three times before they gave birth—30, 60, and 90 days prior.
  • The foals from Group 1 (101 foals) received both immunised mare colostrum and plasma transfusions. In contrast, the foals of Group 2 (14 foals) only received immunised mare colostrum.
  • Results showed the pregnant mare immunization significantly increased the level of R. equi antibodies in colostrum. However, there were eight foals that did not successfully receive the specific R. equi antibody.
  • The incidence of R. equi pneumonia was only 2.9% in Group 1 but surged to 43% in Group 2.
  • This indicated that, unlike plasma transfusion procedure, vaccination of pregnant mares was not effective in protecting foals against R. equi pneumonia.

Conclusion

  • Overall, the fluid transfusion process of injecting hyperimmune plasma — prior to R. equi exposure — was found to be significantly protective against R. equi pneumonia for the foals.
  • On the other hand, the strategy of vaccinating pregnant mares to bolster the colostrum’s R. equi antibody did not similarly protect against R. equi pneumonia.

Cite This Article

APA
Madigan JE, Hietala S, Muller N. (1991). Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J Reprod Fertil Suppl, 44, 571-578.

Publication

ISSN: 0449-3087
NlmUniqueID: 0225652
Country: England
Language: English
Volume: 44
Pages: 571-578

Researcher Affiliations

Madigan, J E
  • Department of Medicine, University of California, Davis 95616.
Hietala, S
    Muller, N

      MeSH Terms

      • Actinomycetales Infections / immunology
      • Actinomycetales Infections / veterinary
      • Animals
      • Antibodies, Bacterial / analysis
      • Enzyme-Linked Immunosorbent Assay
      • Female
      • Horse Diseases / immunology
      • Horses / immunology
      • Maternal-Fetal Exchange
      • Pneumonia / immunology
      • Pneumonia / veterinary
      • Pregnancy
      • Rhodococcus equi / immunology
      • Vaccines, Inactivated / administration & dosage
      • Vaccines, Inactivated / immunology

      Citations

      This article has been cited 18 times.
      1. Knox A, Zerna G, Beddoe T. Current and Future Advances in the Detection and Surveillance of Biosecurity-Relevant Equine Bacterial Diseases Using Loop-Mediated Isothermal Amplification (LAMP). Animals (Basel) 2023 Aug 18;13(16).
        doi: 10.3390/ani13162663pubmed: 37627456google scholar: lookup
      2. Palmisano M, Javsicas L, McNaughten J, Gamsjäger L, Renaud DL, Gomez DE. Effect of plasma transfusion on serum amyloid A concentration in healthy neonatal foals and foals with failure of transfer of passive immunity. J Vet Intern Med 2023 Mar;37(2):697-702.
        doi: 10.1111/jvim.16647pubmed: 36825688google scholar: lookup
      3. Kahn SK, Cywes-Bentley C, Blodgett GP, Canaday NM, Turner-Garcia CE, Flores-Ahlschwede P, Metcalfe LL, Nevill M, Vinacur M, Sutter PJ, Meyer SC, Bordin AI, Pier GB, Cohen ND. Randomized, controlled trial comparing Rhodococcus equi and poly-N-acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals. J Vet Intern Med 2021 Nov;35(6):2912-2919.
        doi: 10.1111/jvim.16294pubmed: 34738651google scholar: lookup
      4. Kahn SK, Cywes-Bentley C, Blodgett GP, Canaday NM, Turner-Garcia CE, Vinacur M, Cortez-Ramirez SC, Sutter PJ, Meyer SC, Bordin AI, Vlock DR, Pier GB, Cohen ND. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia. PLoS One 2021;16(8):e0250133.
        doi: 10.1371/journal.pone.0250133pubmed: 34437551google scholar: lookup
      5. Cohen ND, Kahn SK, Cywes-Bentley C, Ramirez-Cortez S, Schuckert AE, Vinacur M, Bordin AI, Pier GB. Serum Antibody Activity against Poly-N-Acetyl Glucosamine (PNAG), but Not PNAG Vaccination Status, Is Associated with Protecting Newborn Foals against Intrabronchial Infection with Rhodococcus equi. Microbiol Spectr 2021 Sep 3;9(1):e0063821.
        doi: 10.1128/Spectrum.00638-21pubmed: 34319137google scholar: lookup
      6. Harvey AB, Bordin AI, Rocha JN, Bray JM, Cohen ND. Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi. J Vet Intern Med 2021 Jan;35(1):590-596.
        doi: 10.1111/jvim.16002pubmed: 33326149google scholar: lookup
      7. Folmar CN, Cywes-Bentley C, Bordin AI, Rocha JN, Bray JM, Kahn SK, Schuckert AE, Pier GB, Cohen ND. In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly-N-acetyl glucosamine hyperimmune plasma compared to commercial plasma products. J Vet Intern Med 2019 May;33(3):1493-1499.
        doi: 10.1111/jvim.15511pubmed: 31034109google scholar: lookup
      8. Rocha JN, Cohen ND, Bordin AI, Brake CN, Giguère S, Coleman MC, Alaniz RC, Lawhon SD, Mwangi W, Pillai SD. Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi. PLoS One 2016;11(2):e0148111.
        doi: 10.1371/journal.pone.0148111pubmed: 26828865google scholar: lookup
      9. Bordin AI, Pillai SD, Brake C, Bagley KB, Bourquin JR, Coleman M, Oliveira FN, Mwangi W, McMurray DN, Love CC, Felippe MJ, Cohen ND. Immunogenicity of an electron beam inactivated Rhodococcus equi vaccine in neonatal foals. PLoS One 2014;9(8):e105367.
        doi: 10.1371/journal.pone.0105367pubmed: 25153708google scholar: lookup
      10. Erganis O, Sayin Z, Hadimli HH, Sakmanoglu A, Pinarkara Y, Ozdemir O, Maden M. The effectiveness of anti-R. equi hyperimmune plasma against R. equi challenge in thoroughbred Arabian foals of mares vaccinated with R. equi vaccine. ScientificWorldJournal 2014;2014:480732.
        doi: 10.1155/2014/480732pubmed: 24982958google scholar: lookup
      11. van der Geize R, Grommen AW, Hessels GI, Jacobs AA, Dijkhuizen L. The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development. PLoS Pathog 2011 Aug;7(8):e1002181.
        doi: 10.1371/journal.ppat.1002181pubmed: 21901092google scholar: lookup
      12. Oliveira AF, Ruas LP, Cardoso SA, Soares SG, Roque-Barreira MC. Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. PLoS One 2010 Jan 13;5(1):e8644.
        doi: 10.1371/journal.pone.0008644pubmed: 20072623google scholar: lookup
      13. Hines SA, Stone DM, Hines MT, Alperin DC, Knowles DP, Norton LK, Hamilton MJ, Davis WC, McGuire TC. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes. Clin Diagn Lab Immunol 2003 Mar;10(2):208-15.
      14. Lopez AM, Hines MT, Palmer GH, Alperin DC, Hines SA. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin Diagn Lab Immunol 2002 Nov;9(6):1270-6.
      15. Darrah PA, Hondalus MK, Chen Q, Ischiropoulos H, Mosser DM. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 2000 Jun;68(6):3587-93.
      16. Kasuga-Aoki H, Takai S, Sasaki Y, Tsubaki S, Madarame H, Nakane A. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology 1999 Jan;96(1):122-7.
      17. Nay TS. Extra-pulmonary Rhodococcus equi in a thoroughbred foal. Can Vet J 1996 Oct;37(10):623-4.
        pubmed: 8896881
      18. Kabir A, Lamichhane B, Habib T, Adams A, El-Sheikh Ali H, Slovis NM, Troedsson MHT, Helmy YA. Antimicrobial Resistance in Equines: A Growing Threat to Horse Health and Beyond-A Comprehensive Review. Antibiotics (Basel) 2024 Jul 29;13(8).
        doi: 10.3390/antibiotics13080713pubmed: 39200013google scholar: lookup